Zinman was one of three Canadian principal investigators leading the U.S.-Canada Diabetes Control and Complications Trial (DCCT), which was launched in 1982 across 29 hospitals and universities; this large type 1 diabetes complications study set out to determine whether intensive or conventional treatment was more effective in tackling diabetic complications.